Scinovex
article Open AccessTop 1% cited

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Annals of Oncology · 2011 · Vol. 22(8) · pp. 1736–1747
Aron GoldhirschW. C. WoodAlan S. CoatesRichard D. GelberBeat ThürlimannHans-Jörg Senn
Breast Cancer Treatment StudiesHER2/EGFR in Cancer ResearchBreast Lesions and CarcinomasMedicineTrastuzumabBreast cancerOncologySystemic therapyDiseaseInternal medicineCancerRadiation therapyTargeted therapy

MeSH terms

TrastuzumabAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsBreast NeoplasmsConsensus Development Conferences as TopicConsensus Statements as TopicFemaleHumansNeoplasm StagingChemotherapy, AdjuvantDisease-Free SurvivalReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesAntineoplastic Agents, Hormonal

Funding

  • Amgen
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Genomic Health
  • Università degli Studi di Milano
  • Ipsen
  • Genentech
  • Winship Cancer Institute
  • National Cancer Institute
Citations
3,850
FWCI
110.70
field-weighted impact
References
99
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 · Scinovex